We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 10, 2010

MALLINCKRODT INC. V. WATSON LABORATORIES, INC.-FLORIDA

Track this case

Case Number:

2:10-cv-06424

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Faith S. Hochberg

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 25, 2012

    Covidien Makes Deal With Watson To Allow Generic Exalgo

    Zalicus Inc. on Wednesday said Covidien PLC, with which it partners on Covidien's painkiller Exalgo, has agreed to a settlement with Watson Pharmaceuticals Inc. that will allow a generic version of Exalgo to hit the market before the expiration of Covidien's patent.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS